Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study

Schizophrenia Research
P D HarveyM Davidson

Abstract

Cognitive impairment is increasingly recognized as an important aspect of schizophrenia. Since cognitive impairment has many features in common with the negative symptoms of the illness, it is possible that some of the characteristics attributed to negative symptoms are due to an association with cognitive impairments. In order to test this hypothesis, 174 chronically hospitalized geriatric schizophrenic patients were examined twice at a 1-year follow-up with ratings of the severity of their symptoms (using the Positive and Negative Syndrome Scale: PANSS) and assessments of cognitive functions with the Mini-Mental State Examination and a brief neuropsychological battery aimed at the typical impairments seen in dementia. Positive symptoms were unassociated with any of the cognitive variables, while negative symptom severity was correlated with each of the cognitive measures. In the cross-temporal analyses, cognitive impairments were more stable over time than negative symptom scores, but cognitive impairment did not predict the severity of any negative symptom over time. At each assessment, however, cognitive impairment was strongly correlated with each of the seven negative symptoms studied. These data indicate that cognitive i...Continue Reading

References

Feb 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·T WykesD Hemsley
Apr 1, 1992·Schizophrenia Research·P D HarveyR C Mohs
Jan 1, 1991·Schizophrenia Bulletin·K T MueserR L Morrison
Sep 1, 1991·Schizophrenia Research·J AddingtonE Maticka-Tyndale
Apr 15, 1991·Biological Psychiatry·J GeddesP Pratt
Dec 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·T WykesR Katz
Jan 1, 1990·Schizophrenia Bulletin·P D HarveyM Rasmussen
Jan 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·E C JohnstoneT J Crow
Jan 1, 1985·Schizophrenia Bulletin·M F Pogue-Geile, M Harrow
Jan 1, 1984·Schizophrenia Bulletin·M F Pogue-Geile, M Harrow
Dec 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·B Pfohl, G Winokur
May 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·P D HarveyM Davidson
Nov 1, 1994·Psychiatry Research·A M KringP D Harvey
Jan 1, 1994·Schizophrenia Bulletin·B A Cornblatt, J G Keilp
Jan 1, 1993·Schizophrenia Bulletin·T E GoldbergD R Weinberger
Jan 1, 1988·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·A MedaliaA Merriam

❮ Previous
Next ❯

Citations

Aug 25, 2011·The Psychiatric Quarterly·Jharna N ShahPaul E Schulz
Aug 27, 2004·Schizophrenia Research·Elena AntonovaVeena Kumari
Jan 23, 1999·Biological Psychiatry·J I FriedmanK L Davis
Apr 1, 1997·Pharmacology, Biochemistry, and Behavior·A M Mortimer
Mar 11, 2004·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·C R BowieK L Davis
Jun 6, 2002·Schizophrenia Research·Thomas McBrideRaquel E Gur
Nov 5, 2002·Schizophrenia Research·Catherine HughesTonmoy Sharma
Nov 25, 2003·Schizophrenia Research·Judith JaegerStefanie M Berns
Nov 24, 1998·Schizophrenia Research·J Addington, D Addington
Mar 26, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Michael PoyurovskyRonit Weizman
Feb 9, 2005·Molecular Psychiatry·J L RapoportM R C Psych
Apr 28, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Richard S E KeefeJeffrey A Lieberman
Dec 29, 2000·The Australian and New Zealand Journal of Psychiatry·J Hallmayer
Dec 29, 2000·The Australian and New Zealand Journal of Psychiatry·V CarrT Lewin
Dec 29, 2000·The Australian and New Zealand Journal of Psychiatry·S A Halpin, V J Carr
Oct 14, 2005·Schizophrenia Bulletin·Philip D HarveyChristopher R Bowie
Nov 24, 2004·The Australian and New Zealand Journal of Psychiatry·Andrew GumleyMatthias Schwannauer
May 4, 1999·Acta Psychiatrica Scandinavica. Supplementum·M T Tsuang, S V Faraone
Jun 8, 2002·Annual Review of Neuroscience·David A Lewis, Pat Levitt
Jul 4, 2003·The Journal of Clinical Investigation·Tonmoy Sharma
Aug 16, 2011·Journal of Personality Disorders·Alex S Cohen, S Lee Hong
Jan 30, 2014·Annual Review of Clinical Psychology·P Fusar-PoliT H McGlashan
May 31, 2001·Acta Psychiatrica Scandinavica·T K LarsenP Vaglum
Apr 2, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Andrei SzökeMarion Leboyer
Jan 1, 2006·Indian Journal of Psychiatry·J K Trivedi
Nov 8, 2014·Behavioral Sciences·Linette Lawlor-Savage, Vina M Goghari
Jan 25, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Carl I CohenDishal Solanki
Sep 3, 2010·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Fayaz IbrahimPaul M Ramirez
Oct 16, 2004·Journal of Clinical Pharmacy and Therapeutics·X S RenL E Kazis
Jan 22, 2005·Journal of Clinical Pharmacy and Therapeutics·X S RenL Kazis
Oct 9, 2003·Acta Psychiatrica Scandinavica·I HellingC M Hultman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.